129
Participants
Start Date
May 22, 2025
Primary Completion Date
January 31, 2028
Study Completion Date
August 31, 2028
Romiplostim N01 combined with dexamethasone
Dexamethasone (HD-DXM) at a dose of 40mg/d for 4 days constitutes one cycle. If there is no response on the 10th day, repeat it once. The administration can be either oral or intravenous. Meanwhile, romiplostim N01 is administered with an initial dose of 3µg/kg by subcutaneous injection within 4 days of dexamethasone treatment once a week for up to 6 months.
Dexamethasone monotherapy
Dexamethasone (HD-DXM) 40mg/d × 4 days, one cycle. If there is no response on the 10th day, repeat once, administered either orally or intravenously.
RECRUITING
Chinese Academy of Medical Science and Blood Disease Hospital, Tianjin
Collaborators (1)
Weifang People's Hospital
OTHER
Shenzhen Second People's Hospital
OTHER
The Affiliated Hospital of Qingdao University
OTHER
The Affiliated Hospital of Nantong University
UNKNOWN
The First Affiliated Hospital of Bengbu Medical University
OTHER
The Second Affiliated Hospital of Dalian Medical University
OTHER
Affiliated Hospital of North Sichuan Medical College
OTHER
Changzhi Medical College
OTHER
North China University of Science and Technology
OTHER
Tianjin Hospital of ITCWM-Nankai Hospital
UNKNOWN
Baoding First Central Hospital
OTHER
Institute of Hematology & Blood Diseases Hospital, China
OTHER